Yuce Bio
Latest round
- Series C
Last raised
- Aug 2020
Total raised
- $44M
Investors
- 3
About Yuce Bio
Based in Shenzhen, China and established in 2015, Yuce Bio is a tumor immune diagnosis and treatment platform that focuses on the detection technology of tumor neoantigens to carry out product development, transformation, and commercial promotion. The company provides clinical medication guidance, dynamic monitoring and testing products for tumor patients. Also, it provides companion diagnosis and treatment target development service for pharmaceutical companies, based on the company's tumor neoantigen detection and identification platform, tumor immune multi-dimensional detection and research platform, tumor bio-information interpretation database, tumor immune diagnosis and treatment real-world research database. It's business covered more than 40 cities, and 200 hospitals. The company provides tumor clinical testing and clinical research, pharmaceutical R&D services, companion diagnosis-in vitro diagnostic reagents (CDx-IVD). The company plans to continue develop clinical precision diagnosis, and immunological drug development, around tumor immunity. Also, it will build a tumor immunity diagnosis platform, based on privacy computing and data security.
Who invested in Yuce Bio
3 investors across 3 rounds
See all investors in Yuce Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Yuce Bio
Who invested in Yuce Bio?
Yuce Bio has 3 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Yuce Bio raised?
Yuce Bio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Yuce Bio last raise money?
Yuce Bio's most recent round on record is a Series C, in Aug 2020.
What does Yuce Bio do?
Based in Shenzhen, China and established in 2015, Yuce Bio is a tumor immune diagnosis and treatment platform that focuses on the detection technology of tumor neoantigens to carry out product development, transformation, and commercial promotion.
Where is Yuce Bio headquartered?
Yuce Bio is headquartered in Shenzhen, China.
Which VCs invest in companies like Yuce Bio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Yuce Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Yuce Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.